Another clinical study measuring cerebrospinal fluid levels of CCK found that higher CCK was associated with a decreased likelihood of having mild cognitive impairment or AD, suggesting that CCK may serve as a biomarker of neural integrity, and cognitive performance in AD (Plagman et al., 2019). Here, CCK is linked to Alzheimer disease.